The charing cross hospital experience with temozolomide in patients with gliomas

This publication has 27 references indexed in Scilit:

• A Registration and Interpolation Procedure for Subvoxel Matching of Serially Acquired MR Images
  Journal of Computer Assisted Tomography, 1995
• Survival in patients with recurrent glioma as a measure of treatment efficacy: Prognostic factors following nitrosourea chemotherapy
  European Journal Of Cancer, 1994
• Temozolomide: A new oral cytotoxic chemotherapeutic agent with promising activity against primary brain tumours
  European Journal Of Cancer, 1993
• Enhancement of Nitrosourea Activity in Medulloblastoma and Glioblastoma Multiforme
  JNCI Journal of the National Cancer Institute, 1992
• A randomized study of chemotherapy with procarbazine, vincristine, and lomustine with and without radiation therapy for astrocytoma grades 3 and/or 4
  Cancer, 1991
• Prognostic factors for high-grade malignant glioma: Development of a prognostic index
  Journal of Neuro-Oncology, 1990
• The role of chemotherapy in the treatment of gliomas in adults
  Cancer Treatment Reviews, 1989
• A randomized study of CCNU with and without benznidazole in the treatment of recurrent grades 3 and 4 astrocytoma: Report to the Medical Research Council by the Brain Tumor Working Party
  International Journal of Radiation Oncology*Biology*Physics, 1989
• Correlation between O⁶-methylguanine-DNA-methyltransferase activity and resistance of human cells to the cytotoxic and mutagenic effect of N-methyl-N′-nitro-N-nitrosoguanidine
  Carcinogenesis: Integrative Cancer Research, 1984
• Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas
  Journal of Neurosurgery, 1978